Thanks for the kudos, gfp. I doubt if I deserve it. From 2015-2019, my biotech stock picking was decidedly inferior.
Let me go through your list:
ADRO----Don't own it. Haven't followed it in a while.
CRDF----Huge position for me now. Have been loading up under $17
CHMA----Sold out. I, generally, don't like execution stories.
CXXI----Made millions. Still hold 30% of my shares. May be fairly valued.
KZIA----I own a ton. Will lose it all or make millions. Highly spec.
KURA----Sold out way too early. Too rich for me now.
MGNX----Sold out way too early. Maybe too rich for me now.
MEIP----Just bought a little (for me), but color me skeptical
NERV----Sold out after recent drug failure.
MGTA----Sold out. Lost a ton. May buy back next year. Still like it.
OTIC----Sold out. No plans to re-enter.
PIRS----Own a miniscule position. Can't get a handle on it.
PRVB----My largest position. Way undervalued, IMO.
SYBX----Don't own it, don't follow it.
XENE----Sold out, but still high on my watch list.
TRIL----Lost a ton. Stock went to $.24. Should have bought. Stupid me. It's in my Contest portfolio. The leader in the Contest, jbog, had it as his largest position. He's up over 200% in the Contest!!! I recently bought back at $13.20. If FTSV is worth over $4 billion, then TRIL should be worth more down the line.
MYOV----Own a fair amount, but not for endometriosis. The value is in prostate cancer.
Dewdiligence ("Dew") likes ENTA & RVNC. Should always give Dew his due. Incredibly smart guy.
The "sleeper" here is KZIA. Will be presenting at SNO (Society of Neuro-Oncology) next week. Could be some important news. One-drug Australian nano-cap biotech. Crazy, huh? But that drug came from Genentech lab.
If we don't have an attempted coup or a divided Presidency or blood in the streets, Market should be fine, once we get COVID under control.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.